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Antigen receptor-mediated signaling is critical for the
development and survival of B cells. However, it has
not been established whether B cell development re-
quires a signal from self-ligand engagement at the im-
mature stage, a process known as “positive selec-
tion.” Here, using a monoclonal B cell receptor (BCR)
mouse line, specific for the self-Thy-1/CD90 glycopro-
tein, we demonstrate that BCR crosslinking by low-
dose self-antigen promotes survival of immature B
cells in culture. In spleen, an increase in BCR signal-
ing strength, induced by low-dose self-antigen, di-
rected naive immature B cells to mature, not into the
default follicular B cell fate, but instead into the mar-
ginal-zone B cell subset. These data indicate that pos-
itive selection can occur in developing B cells and
that BCR signal strength is a key factor in deciding
between two functionally distinct mature B cell com-
partments in the microenvironment of the spleen.
Introduction
Lymphocyte development is a dynamic, interactive pro-
cess that takes place in various microenvironments.
For developing T cells, it has been established that an-
tigen receptor signaling due to self-ligand engagement
critically affects the fate of these lymphocytes, either
positively or negatively. During T cell development in
thymus, binding of self major histocompatibility com-
plex ligand by T cell receptor in a low-affinity interac-
tion prevents immature cell death, resulting in “positive
selection” (Kisielow et al., 1988; Jameson et al., 1995).
Subsequent development into functionally distinct CD4
or CD8 subsets appears to be determined by a balance
of strength and duration of TCR signal, influenced by
coreceptors (Yasutomo et al., 2000; Werlen et al., 2003).
In comparison, it remains uncertain whether B cell de-
velopment also requires positive selection (Healy and
Goodnow, 1998). Previous studies with BCR signaling-
deficient or mutant mice have clearly established the
dependence of B cell development on antigen receptor
signaling, from the early pre-B to the mature B cell
stages (Turner et al., 1995; Benschop and Cambier,
1999; Reichlin et al., 2001; Kraus et al., 2004). However,
it remains unclear whether, and to what extent, such
BCR signal dependence reflects a requirement for posi-*Correspondence: k_hayakawa@fccc.edu
1Present address: Department of Internal Medicine and Rheumatol-
ogy, Juntendo University School of Medicine, Tokyo 113, Japan.tive selection mediated by self-ligand engagement, or
instead basal signaling that occurs even in the absence
of ligand (Reth et al., 2000; Roose et al., 2003).
Most mature B cells in the lymphoid organs are of
bone marrow (BM) origin. Immature B cells are formed
in the BM and mature in secondary peripheral sites,
predominantly in the spleen, generating two histologi-
cally, phenotypically, and functionally distinct mature B
cell subsets: “follicular B cells” (FO B) and “marginal-
zone B cells” (MZ B) (Kumararatne et al., 1981; Martin
and Kearney, 2002). FO B cells are small recirculating
IgMlowIgDhi lymphocytes, forming the B cell follicles
within the white pulp, eventually developing into the
predominant mature B cell population in adults. In com-
parison, MZ B cells are identified as medium-sized
IgMhiIgDlo lymphocytes resident in the spleen marginal
zone at the white pulp-red pulp junction (Kumararatne
et al., 1981). MZ B cells are the major constituent of the
marginal zone, together with myeloid, dendritic, and
stromal cells. Although the marginal zone is a transit
site for reentering B cells and various activated B cells
can be found in the marginal zone (Liu et al., 1988), the
majority of B cells in the marginal zone of unimmunized
animals appear to be “naive,” i.e., they are resident
even in germ-free animals (Kumararatne and MacLen-
nan, 1982). Such naive B cells in the marginal zone ex-
hibit distinct phenotypic features, such as high expres-
sion of the complement receptor, CD21 (Kumararatne
et al., 1981; Martin and Kearney, 2002), and the ability
to respond rapidly to certain antigens or pathogens fil-
tered from the blood stream (Guinamard et al., 2000;
Martin and Kearney, 2002). These characteristics sug-
gest that MZ B cells play a specialized function, which
acts in synergy with and complements adaptive immu-
nity that is initiated by FO B cells in concert with T cells
(Martin and Kearney, 2002).
There are several competing hypotheses concerning
the MZ B cell developmental pathway in relation to the
FO B subset (Kumararatne and MacLennan, 1982;
Dammers et al., 1999; Martin and Kearney, 2002), in-
volving such issues as the role of antigen and the
strength of BCR signal (Martin and Kearney, 2002; Pillai
et al., 2005), leading to speculation on the role of self-
antigen in mediating FO/MZ B cell subset determina-
tion. In addition, recent discoveries on the critical role
of non-BCR signaling in B cell development make the
role of BCR signaling more difficult to incorporate into
a unified hypothesis. BAFF, a member of the tumor ne-
crosis factor family produced from a myeloid/dendritic
cells, which is known to activate the NF-κB pathway,
is essential for both FO and MZ B cell development
(Schiemann et al., 2001; Mackay and Browning, 2002).
MZ B cell development further specifically involves ac-
tivation of the extracellular developmental signaling
molecule, Notch 2 (Saito et al., 2003), by ligation with
delta-like 1(Hozumi et al., 2004), in addition to distinc-
tive migration (Guinamard et al., 2000; Fukui et al.,
2001; Girkontaite et al., 2001) and retention mecha-
nisms (Lu and Cyster, 2002; Cinamon et al., 2004).
Taken together, the differences in these mechanisms
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ferentiation, in the context of the spleen, with poten-
tially complex interactions between BCR and non-BCR-
mediated signaling pathways.
To explore the effects of self-antigen-mediated BCR
signaling, in this study we examined the development
of B cells bearing BCR immunoglobulin (Ig) for the Thy-1/
CD90 glycoprotein (anti-Thy-1 autoantibody; ATA). In
the Ig H/L transgenic mouse line 3369, essentially all
immature B cells express the transgenic ATA IgM BCR,
encoded by germline IgH/L genes (Hayakawa et al.,
2003). The ATA BCR recognizes a species- and cell
type-specific glycoepitope on mouse Thy-1 (Thy-16C10)
as a self-antigen, abundantly produced by thymocytes
from all strains of mice (Gui et al., 1999). Thy-1 is a
25–30 Kd GPI (glycosylphosphatidylinositol)-anchored
membrane glycoprotein that can be cleaved and re-
leased from the cell surface (Vitetta et al., 1974; Low
and Kincade, 1985; Bergman and Carlsson, 1994). Thy-
16C10/ATA BCR signaling is able to mediate both posi-
tive and negative effects by exposure to Thy-1 self-anti-
gen. The presence of Thy-1 antigen in a normal Thy-1+
environment promotes B-1 B cell development as a mi-
nor B cell subset, producing ATA in serum, as a type of
positive selection (Hayakawa et al., 1999). In contrast,
an arrest of maturation is observed in spleen where
bone marrow-derived B cell development/maturation is
normally completed. Thus, as a consequence of nega-
tive selection, FO B and MZ B cells are absent (Haya-
kawa et al., 2003). However, a lack of Thy-1 engage-
ment in Thy-1-deficient gene-targeted mice permits
ATA B cell maturation to proceed to the IgMlo FO B cell
subset (Hayakawa et al., 2003). This transgenic model
system allowed us to assess the relative effect of dif-
ferent BCR signal strength on naive immature B cells
by altering Thy-1 antigen quantity in mice and also in
culture to modulate the BCR crosslinking signal. We
demonstrate here the critical role of BCR signaling
strength in determination of B cell subset fate and its
consequent influence on Notch 2 susceptibility.
Results
MZ B Cell Development Promoted by Self-Antigen
In 3369 ATA mice with a Thy-1+ wild-type background,
exposure to self-Thy-1 antigen resulted in a block of
development of most splenic ATA B cells at the imma-
ture CD24hiCD21– stage (Figure 1A, wt; Hayakawa et
al., 2003). In the absence of Thy-1, using Thy-1 gene-
targeted mice, ATA B cells progressed to populate a
typical mature FO B cell compartment, as demon-
strated by a CD24loCD21medCD23hi phenotype (Figure
1A, ThyKO; Hayakawa et al., 2003). Surprisingly, when
the ATA BCR was expressed on a Rag-1 (recombination
activating gene-1) null background, there was exclusive
development of B cells with a typical MZ B phenotype
in the spleen (Figure 1A, RagKO). This CD24medCD21hi
CD23lo B cell development was specific to the spleen
and was not found in lymph nodes, peripheral blood,
or the peritoneal cavity (see Figure 1A legend). These
MZ B cells arose from an apparently normal population
of immature B cells, as assessed by surface phenotype





























































ip to 2 weeks of age, without generation of the
D24loCD21medFO B cell population during the 8–10
eek period (data not shown). There was no CD5+
-1 cell generation in all locations (data not shown). An
ccumulation of B cells in the marginal zone became
rominent by 8 weeks of age (Figure 1B). This MZ B
ell development by ATA-expressing cells was accom-
anied by the appearance of large numbers of Ig-pro-
ucing plasma cells in the red pulp of the spleen (Figure
B, arrow). There was also Thy-1-dependent serum ATA
ntibody (Figure 1C, compare RagKO and RagKO-
hyKO), at 70% of the level found in wt ATA mice, pro-
uced from B-1 cells (Hayakawa et al., 2003). ATA MZ B
ells present in RagKO background animals are direct
recursors for the spleen plasma cells, also contribut-
ng to serum ATA, as shown by MZ B cell transfer to
ontransgenic RagKO recipients (data not shown). This
as a very different picture from the low amount of
pontaneous ATA production in ThyKO mice (Figure
C). These data suggest that, similar to B-1 cells, MZ
cell development could occur independently of FO B
ell formation and these cells could contribute to serum
utoantibody production in the absence of T cells.
In RagKO mice, the amount of self-Thy-1 antigen is
xpected to be significantly reduced from wild-type
evels, due to a block early in T cell development, but
t will not be absolutely lacking due to the expression
f Thy-1 antigen by residual immature thymocytes (cor-
esponding to about 1% of wild-type numbers, see Fig-
re S1A in the Supplemental Data available with this
rticle online). Therefore, we tested whether distinctive
Z B development in RagKO background mice was
ue to the absence of T cells or, instead, to the pres-
nce of low levels of antigen, by performing cell
ransfers of hematopoietic stem cells from 3369ThyKO
ouse bone marrow into either RagKOThyKO or RagKO
ecipients (Figure 1D). In both types of transfers, T cells
ill be generated from the stem cells and any cell types
rising from donor bone marrow will lack expression of
hy-1. Although B cells and T cells were engrafted at
imilar high levels in both cases (30%–40% B and 40%
cells), generation of the CD21hi MZ B cell phenotype
ccurred only in the RagKO recipients. In clear con-
rast, in the RagKOThyKO recipients, engrafted mature
cells showed a FO B cell phenotype. A predominance
f B cells with the distinctive MZ B cell phenotype was
een 1–2 months after transfer into RagKO recipients,
hen most of the B cells with MZ B cell phenotype
ere still within the white pulp (data not shown). More
han 5 months after transfer, nearly all B cells in the
agKO mice were located in the MZ, in clear contrast
o the FO B cells predominating in RagKOThyKO recipi-
nts (Figure 1D). MZ B cell development was also asso-
iated with higher ATA serum titers than seen with FO
cell development (data not shown). Thus, the pres-
nce of self-antigen was a critical environmental factor,
romoting development of ATA B cells toward a MZ B
ell fate in the spleen, rather than a FO B cell fate.
TA MZ B Cell Development by Low
mount of Self-Antigen
lthough our data with RagKO mice demonstrated the
mportance of Thy-1 antigen in MZ B cell development,
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299Figure 1. Self-Antigen Mediates Exclusive Development of ATA B Cells to the MZ B Cell Compartment in 3369RagKO Mice
(A) Spleen ATA B cells from 2-month-old 3369 mice on wild-type (wt), Thy-1 gene knockout (ThyKO), or Rag-1 gene knockout (RagKO)
background. Dagger indicates short lived. Total spleen cell numbers were similar (7–10 × 107) in analysis of more than 10 mice per group.
ATA B cells were gated as ATA idiotype+ B220+ (and endogenous IgMb–) cells. ATA B cells in spleen of wt, ThyKO, and RagKO background
were 30%–35%, 40%–50%, and 70%–80%, respectively. In 3369RagKO mice, nearly all ATA B cells circulating in blood were at the immature
AA4+CD21lo/– CD24hi stage. Lymph nodes were undetectable in RagKO, except for the mesenteric lymph nodes, where ATA B cells (30%)
showed a somewhat progressed but still immature phenotype (AA4lo/– CD21lo CD24hiCD23med/–), with a lack of CD21hi cells. There was no
increase in peritoneal cavity resident cell number (2 × 106 cells) in 3369RagKO mice, where ATA B cells were 60%–80% of total, with a more
differentiated phenotype reminiscent of “B1b” (AA4–CD21lo+CD24medCD5–CD11blo+), either CD23+ or CD23–. Thus, CD21hi ATA B cells were
restricted to the spleen.
(B) Staining of spleen sections from 3369RagKO mice at indicated ages, from primordial follicle (4 days) to typical MZ B cell expansion at 8
weeks of age. MZ B cell development was accompanied by the appearance of ER-TR9+ macrophage clusters in the MZ, CR1/2hi+ follicular
dendritic cells within the white pulp, and plasma cells with high cytoplasmic IgM content in the red pulp (indicated by arrow).
(C) Self-antigen-dependent serum ATA production in 3369RagKO mice, similar to that from B-1 B cells in wt mice. Sera from 3369 mice on
different backgrounds as indicated. Data from 5 samples per group.
(D) Self-antigen-dependent ATA MZ B cell development from 3369ThyKO stem cells. Spleen ATA B cell analysis and spleen section staining
5 months after stem cell transfer. Representative of 4 mice per group.it was unclear whether this ATA MZ B cell development
was due to an abnormally lower amount of antigen in
RagKO than normal or else to a unique expression ofThy-16C10, possibly by non-T lineage cells, in RagKO
mice. In normal mice, Thy-16C10 is a mouse- and cell
type-specific glycoepitope, predominantly restricted to
Immunity
300the T cell lineage, and not (or poorly) expressed on Thy-
1 glycoprotein of brain cells, natural killer cells, or bone
marrow stromal cells (Gui et al., 1999); furthermore,
there was no significant expression detectable on cells
of other organs (see Figure S2D, wt). However, rare Thy-
16C10+ nonlymphoid cells could conceivably play a criti-
cal role. Thus, to test whether the quantity of self-anti-
gen produced from thymocytes was a critical factor, we
generated a series of Thy-1 transgenic mouse lines,
with Thy-1 expression driven by the proximal lck pro-
moter and, thus, preferentially expressed by immature
thymocytes (Chaffin et al., 1990). Lines expressing
moderately higher, moderately lower, or much lower
levels of Thy-16C10, compared to wild-type levels, were
selected, bred to a ThyKO background, and then crossed
with 3369ThyKO mice, so that the thymocyte/T cell-
derived transgene Thy-1 was the only source of Thy-1
self-antigen (see Figures S2C and S2D).
We found that T cell development and early bone
marrow ATA B cell development proceeded similarly in
all mice. Importantly, the effect of self-antigen dose
was readily apparent from analysis of ATA B cells in the
spleen. Figure 2 shows analyses of surface phenotype
(Figure 2A), histology (Figure 2B), serum ATA level (Fig-
ure 2C), and calcium signaling (Figure 2D) in splenic
ATA B cells. Antigen expression at levels moderately
higher than wild-type (lck-Thy 130) resulted in a B cell
maturation arrest in an anergic state, as defined by ab-
sence of BCR-mediated calcium flux, similar to the situ-
ation in Thy-1 wild-type mice (Figures 2A and 2D, and
see Figure S1B; Hayakawa et al., 2003); thus, negative
selection occurred by expression of transgene Thy-1.
Lower Thy-1 levels allowed more maturation, a less an-
ergic state (Figure 2D), a progressive increase in the
numbers of B cells with a CD21hi MZ B cell phenotype
(Figure 2A), and an expanded MZ histology (Figure 2B,
lck-Thy 10). Serum ATA data provided evidence of a
positive effect by the presence of transgene Thy-1 (Fig-
ure 1C), in which lck-Thy 130 mice showed the highest
serum titer and frequency of mature CD5+ B-1 cells in
the peritoneal cavity (see Figure 1C legend), similar to
3369 wt. These effects were not observed in the Thy-1-
negative littermate controls, marked “Thy 0” (Figures
2A–2D), which showed a predominance of mature FO
B cells. Functionally, the MZ B cells generated in lck-
Thy 10 mice were distinctive as compared to naive ma-
ture B cells, exhibiting rapid and elevated calcium sig-
naling when stimulated with Thy-1 antigen (Figure 2D),
resembling the calcium signaling seen in MZ B cells
from 3369 RagKO mice (see Figure S1B). The relative
amount of Thy-16C10 found in the thymus correlates
with serum Thy-1 glycoprotein level (as will be shown
below), and peripheral exposure of B cells to such anti-
gen was suggested by a dose-dependent, surface CD5
induction on ATA B cells (Figure 2E; Teutsch et al., 1995;
Azzam et al., 1998). In conclusion, the quantity of
Thy-1 antigen is critical in determining ATA B cell fate
(Figure 2E). Preferential ATA MZ B cell development in
3369 RagKO mouse spleen occurred optimally with
lower amounts of antigen than seen in Thy-1 wild-type
ATA mice.
Positive Selection at the Immature Stage





























































Psequences of self-antigen on MZ B cell development,t remained unclear whether these observations could
e interpreted as positive selection, since the effect of
ntigen might be indirect. Furthermore, it was uncertain
hether any positive effect by antigen fulfilled the clas-
ic criteria for positive selection as used in T cell devel-
pment, i.e., rescue of immature cells from death (Kisie-
ow et al., 1988; Jameson et al., 1995). Thus, to directly
ddress the effect of BCR crosslinking signal strength
n immature B cells, we carried out an ex vivo antigen
timulation, using naive immature ATA B cells from
369ThyKO spleen. Though expression of surface IgM
ccurs abnormally early in 3369 mouse BM, due to
ransgene Ig H/L chain coexpression, developmental
nd maturational changes of cell surface phenotype
ere similar to nontransgenic B cells in the absence
f Thy-1 antigen. These included changes in IgM BCR
uantity (Hardy et al., 1982) and acquisition of apopto-
is resistance (Tomayko and Cancro, 1998) during mat-
ration in the spleen, as shown in Figure 3A. Thus, im-
ature AA4 (CD93)+ B cells expressed high levels of
gM with poor in vitro survival, while mature AA4– FO B
ells expressed lower IgM levels and 10 times better
urvival in vitro. AA4+ and AA4– cells correspond to
D24hiCD21– and CD24loCD21med cell populations, re-
pectively (Allman et al., 2001; Hayakawa et al., 2003).
The earliest consequence of BCR signaling was mea-
ured by calcium response of 3369 ThyKO spleen cells
o stimulation with different doses of Thy-1 antigen
Figure 3B). Mature ATA B cells showed a more sus-
ained, higher-amplitude calcium response at the high-
st antigen dose (inhibited by the calcium chelator,
GTA) than did immature B cells (Figure 3B, red). How-
ver, we found that immature B cells were more sensi-
ive to lower antigen doses, being able to generate a
ubstantial [Ca2+]i rise with 10-fold lower antigen levels
Figure 3B, blue) and a slow [Ca2+]i rise at a 100-fold
ower antigen dose than that required by mature cells
Figure 3B, green). When purified B cells were cultured
or 2 days in the presence of different antigen doses
Figure 3C), mature B cells showed an antigen dose-
ependent activation (and proliferation), with the high-
st viability seen at the highest antigen levels. In com-
arison, immature B cells showed a low and biphasic
iability curve: high antigen doses induced relatively
reater cell death, whereas rescue from cell death oc-
urred at lower doses (with an optimum in the 0.1–1
g/ml range; 4–40 pM). Dose-dependent CD5 induction
nd MHC class II upregulation occurred similarly for
oth mature and immature B cells (Figure 3C) and was
nhibited by cyclosporine A (data not shown). Thus,
hile a strong BCR-medited signal led to “negative se-
ection,” a lower BCR signal induced “positive selec-
ion” in immature B cells. Though the AA4+ cells in-
luded some more progressed CD23+ cells (Hayakawa
t al., 2003) with slightly better survival, in addition to
D23– “T1” (Carsetti et al., 1995) cells, further separa-
ion of AA4+ cells into CD23– and CD23+ produced sim-
lar dose-dependent negative and positive selection re-
ults. Thus, positive selection can occur at the early
mmature B cell stage.
ositive Selection by Serum Thy-1
ositive selection may depend on the antigenic form(Healy and Goodnow, 1998), so that soluble Thy-1M
B Cell Subset Decision
301Figure 2. ATA MZ B Cell Development Is Fostered by Low Levels of Self-Antigen
Spleen cell analysis of ATA B cells produced by crossing 3369 ThyKO.C.B17 and lck-Thy-1Tg.ThyKO.C57BL/6 mice.
(A) Differences in spleen ATA B cell surface phenotype. ATA B cells in spleen are gated as in Figure 1A. CD21hi MZ B cell region is marked by
a square region. WT-Thy100 = 3369WT; Thy 0 = Thy-1Tg–/–.ThyKO. Representative of 4 mice per group (see [E]). Total spleen cell numbers
were all similar (7–9 × 107). ATA B cells in spleen of lck-Thy 130, wt, lck-Thy 60, lck-Thy 10, and Thy 0 mice were 30%, 30%, 50%, 50%, and
50%, respectively. In lck-Thy 10 mice, B cells in the lymph nodes and peripheral blood were similar to mature FO B cells (AA4–CD21+CD23+),
but with somewhat higher CD24 expression than naive FO B cells in Thy 0 mice. Peritoneal cavity cell numbers were all similar (2–3 × 106),
where ATA B cells comprised 50%–80% in all Thy-1Tg+ mice but only 20% in Thy-1Tg– mice; CD5+ B cells with typical B-1 cell phenotype
were only detectable in lck-Thy 130 mice. The peritoneal cavity B cells in lck-Thy 10 mice showed a CD5– “B-1b” cell phenotype. Thus,
CD21hi B cell predominance in lck-Thy-1 10 spleen was restricted to the spleen.
(B) Staining of spleen sections from indicated mice.
(C) Serum ATA production promoted by the presence of lck-Thy-1 transgene. Data from 4 mice per group.
(D) Calcium mobilization assay of spleen B cells stimulated with Thy-1M (600 ng/ml) at 4 × 106 spleen cells/ml. Data were gated for B220+ B
cells. Anti-IgM stimulation showed similar trends, where lck-Thy 130 mouse B cells failed to respond, in contrast with Thy 0 mouse B cells
(Figure S4).
(E) ATA B cell fate determined by amount of self-antigen for conventional B cell development/maturation in spleen. Blue columns indicate
surface CD5 levels on total ATA spleen B cells. CD5 level on mature T cells was 60 U (staining units). Black dots represent MZ B cell frequency
out of total ATA B cells in individual mice.membrane may not be equivalent to physiologic Thy-1
self-antigen. Therefore, we next analyzed the effect of
Thy-1 in serum, which is likely the antigenic form expe-
rienced by developing ATA B cells in the periphery. In
humans, thymocytes or T cells are not the major source
of Thy-1 (Vidal et al., 1990); however, soluble Thy-1 is
detectable in human serum by ELISA, presumably re-leased from activated endothelial cells and fibroblasts
(Saalbach et al., 1999). In mice, we found that Thy-1 is
detected in serum of 2-month-old wild-type mice at
about 1.8 ng/ml on average, with similar levels found in
mice lacking B cells (JHKO). Serum Thy-1 in RagKO
mice is significantly reduced, but still detectable (80 pg/
ml) above the background level in ThyKO mice (Figure
Immunity
302Figure 3. Immature ATA B Cell-Positive Se-
lection In Vitro
(A) ATA B cell maturation in 3369 ThyKO
mice. Progressive maturation in the BM (first
panel from left) corresponds to decreasing
AA4 and increasing B220/6B2 and MHC
class II levels. Right three panels show gat-
ing regions of immature (AA4+) and mature
(AA4–) B220+ ATA B cell fractions in 5-week-
old 3369ThyKO mouse spleen, a comparison
of surface IgM levels, and cell viability during
2 day culture of purified B cells. Spleen AA4+
and AA4– B cell data are shown in red and
blue, respectively. In the IgM staining histo-
grams, nontrangenic C.B 17 mouse spleen B
cell IgM level (predominantly mature AA4– B
cells) is shown in black for comparison, and
the thin black line indicates unstained total
B cells.
(B) Differential dose dependence of antigen-
mediated calcium response in immature ver-
sus mature ATA B cells (gated for the analy-
sis as shown in [A]). For right panels, 1 mM
EGTA was added together with antigen.
Spleen cells were stimulated at 4 × 106 cells/
ml. Representative data from four experi-
ments.
(C) 2 day culture of purified ATA B cells
shows positive selection by low-dose anti-
gen. Dotted line indicates baseline viability
without antigen. Data were based on ap-
proximately 20,000 cells analyzed by flow
cytometry for most groups (i.e., 400–4000
live cells) except for activated mature B cell
cultures at higher antigen doses (10 and 20
ng/ml), where 30,000 cells were analyzed. In-
duction of CD5 message from immature B
cells was detectable from 3 hr after stimula-
tion and from day 1 by surface staining in
high-antigen dose cultures (data not shown).
Data shown are representative of eight ex-
periments. U = staining unit.4A, left). We could also detect lck-Thy-1 transgene-
derived Thy-1 in serum, where lck-Thy 130 mice
showed the highest, followed by lck-Thy 60 (Figure 4A,
r
c
aFigure 4. Positive Selection by Serum Thy-1
(A) Serum Thy-1 levels by ELISA assay. Left: sera from 2-month-old wt (C.B17 and BALB/C), JHKO.CB17, and RagKO.BALB/C mice were
compared to their ThyKO counterparts (<0.02 ng/ml). Right: sera from lck-Thy-1 Tg mouse lines and their Thy-1 Tg– counterpart with endoge-
nous Thy-1KO background. Thy-1 content is expressed in either absolute concentration for Thy-1.2 or relative units for Thy-1.1.
(B) Positive selection by serum antigen. 2 day culture of AA4+ immature B cells from 3369ThyKO (ATA B, circle) or from BALB/c (control B,
triangle) mice with or without 1:100 diluted sera from individual JHKO (Thy-1+, blackfilled) or JHKOThyKO (Thy-1–, unfilled) mice. x fold: fold
increase by serum addition relative to medium alone.
low level of anti-Thy-1 antibody staining of ATA B cellsight). B cells appear to be constantly exposed to such
irculating soluble Thy-1 glycoprotein, as suggested by
B Cell Subset Decision
303in peripheral blood, likely due to Thy-1 bound to the
BCR (Figure S3).
To test whether such serum Thy-1 bound by the ATA
BCR could mediate positive selection, we analyzed di-
luted JHKO mouse sera in the immature B cell culture
assay, in comparison to JHKOThyKO sera, attempting
to provide a low-level Thy-1 crosslinking signal compa-
rable to that experienced in low Thy-1-expressing
RagKO or lck-Thy 10 mice. Use of JHKO mouse sera
helps to minimize potential antigen-antibody complex-
mediated effects from serum. As shown in Figure 4B,
Thy-1-containing serum at 1:100 dilution (18 pg/ml, on
average) had a positive effect on cell survival in culture
and induced MHC class II, specific for ATA immature B
cells. These effects were not seen with serum from Thy-
1-negative mice. Thus, B cell-positive selection can oc-
cur as a consequence of exposure to naturally occur-
ring Thy-1 self-antigen in serum.
Notch 2 Signal-Dependent MZ B Cell Differentiation
from Positively Selected Cells
Not unexpectedly, a BCR crosslinking signal alone
failed to induce MZ B cell maturation in culture. It has
been known that Notch 2 signaling is critical for MZ
B cell development, and the spleen microenvironment
provides BAFF, known to promote both FO B cell and
MZ B cell maturation and survival. To assess how these
non-BCR-mediated signals function in self-antigen-
dependent ATA MZ B cell development, an activated
intracellular fragment of Notch 2 (N2IC), linked to GFP
by an IRES, was introduced by retroviral transduction
into immature naive ATA B cells, isolated from the bone
marrow and preexpanded by culture with IL-7.
After withdrawal of IL-7, immature B cells began to
die in cultures with medium alone, resulting in 5% via-
bility after 5–7 days (Figure 5A). Addition of low-dose
antigen or BAFF, separately or in combination, pre-
vented immature B cell death and promoted matura-
tion, inducing CD23 and low levels of CD21, in the ab-
sence of an activated Notch 2 signal (Figure 5A and
legend). The CD23+ cells generated in these cultures
were not fully mature, retaining an IgMhiAA4medium sur-
face phenotype (data not shown), similar to cells at the
transitional CD21lo/med “T2” stage (Allman et al., 2001).
We found that only a combination of all three signals
(antigen, BAFF, and Notch 2) generated CD21hi cells,
including cells with a MZ B cell phenotype, CD21hi
CD23lo/− (Figure 5A, fourth panel, red dots). Signals
from BAFF plus Notch 2 alone (Figure 5A, third panel,
red dots), or from antigen plus BAFF alone (Figure 5A,
fourth panel, blue dots), did not generate significant
numbers of CD21hi cells, indicating that both a BCR
signal and Notch 2 activation were required. Combina-
tion of these three signals led to proliferation and acti-
vation of large CD21hiCD23+ cells (L), while CD21hi
CD23– MZ B cells were of medium-small size (MS), sug-
gesting that MZ B cells differentiated in vitro from the
CD23+ to CD23– cell stage (Figure 5B, middle two pan-
els). These CD21hi cells also showed increased expres-
sion of CD1 on both CD23+ and CD23– subsets (Figure
5B, right two panels), with CD21hiCD23– cells showing
the highest expression of CD9 (data not shown), char-
acteristic of MZ B cells (Martin and Kearney, 2002). Inthe absence of the Notch 2 signal, the contribution of
BCR crosslinking could still be appreciated by observ-
ing increased accumulation of CD23+ cells in cultures
with antigen, relative to those with BAFF alone (Figure
5A, third and fourth panels, blue), together with signifi-
cant upregulation of CD11a integrin αL expression (Fig-
ure 5C; Lu and Cyster, 2002). These results support a
MZ B-FO B subset division model, where Notch 2 sig-
naling plays a role at the late CD21loCD23+ immature B
cell stage, similar to transitional “T2” (Allman et al.,
2001), acting in concert with already initiated positive
selection signals (or signals emanating from moder-
ately increased BCR signaling) in the presence of BAFF,
further upregulating CD21 and facilitating differentia-
tion to the MZ subset (Figure 5D).
Discussion
A key finding of this study is the demonstration that
self-ligand-mediated positive selection can occur at
the immature stage in B cell development. The rescue
of immature cells from death by a BCR crosslinking sig-
nal provides strong support for B cell-positive selec-
tion, and we show here that BCR signal strength plays
a role in determining immature cell maturation into
either of the two functionally distinct FO and MZ B cell
compartments, both in mice and in culture. The promo-
tion of MZ B cell development by exposure to a defined
transgenic antigen, with FO B cell generation in its ab-
sence, indicates a BCR signal strength requirement that
is higher for MZ B cell than for FO B cell development.
Our B cell culture results provided evidence that this
effect of antigen on MZ B cell development is a direct
consequence of antigen-mediated BCR crosslinking on
immature B cells. However, it is also clear from our
study that B cell maturation proceeds in the context of
the microenvironment of the organ, where non-BCR-
mediated signal(s) play equally important roles in regu-
lating B cell development and differentiation. Appa-
rently normal ATA B cell maturation to the FO B cell
subset, occurring in the absence of Thy-1 antigen ex-
posure, appears to be an example of such non-BCR-
mediated effects. The ability to rescue immature cells
from death by either antigen-engaged BCR or BAFF-
mediated signals suggests that, though a positive se-
lection mechanism may not be required for FO B cell
development, an optimal level of BCR ligation may pro-
mote B cell maturation or survival (as FO B cells) if the
signal strength is sufficiently lower than the threshold
required to induce MZ B cells. Importantly, B cell devel-
opment may be more dependent on BCR signals, if
non-BCR maturation signals are deficient in the micro-
environment.
However, understanding signal “strength” requires
caution, since clearly not all BCR engagement leads to
positive selection. As predicted from previous studies
(Healy and Goodnow, 1998; King and Monroe, 2000),
we observed that a commonly used anti-IgM cross-
linking stimulation approach induced mature B cell acti-
vation but failed to rescue immature ATA B cells from
death at all concentrations tested (data not shown).
Though the reasons for such ligand-dependent differ-
ences remain unclear, one plausible factor is the quality
Immunity
304Figure 5. MZ B Cell Differentiation In Vitro
(A) Generation of CD21hi CD23lo/– cells requires BAFF and Notch2 signals, in addition to antigen. Five day immature ATA B cell culture
transduced with N2IC or empty vector. Cell viabilities are shown within the figure. N2IC-GFP+, vector-GFP+, and GFP– cells are presented as
red, green, and blue dots, respectively. N2IC-GFP+ cells comprised approximately 2% of live cells except for the Thy-1M + BAFF group, which
was higher (9.5%). Vector-GFP+ cells comprised approximately 65% of live cells and there was no surface phenotype differences between
empty vector-GFP+ and GFP– cells in all culture groups analyzed. There was no CD21 expression in culture with medium alone (i.e., equal to
the “no stain” control level), indicated as relative CD21 = “1.0.” Data are representative of three experiments.
(B) Activation and MZ B cell differentiation in response to Notch 2 signal. Comparison of size and surface phenotype between N2IC-GFP+
(red), N2IC-GFP– (blue), and Vector-GFP+ (green) cells in Thy-1M + BAFF culture. Middle two panels: N2IC-GFP+ cells gated for large (L) and
medium/small (MS) size. CD21hiCD23– cells (marked by star) were specifically enriched among N2IC-GFP+ cells of medium/small size. Right
two panels: increased CD1d level in N2IC-GFP+ cell, of both large (thin red) and medium/small (thick red) size, in comparison to N2IC-GFP–
cells (blue). There was no CD1 difference in vector-GFP+ (green) versus GFP– (blue) cells.
(C) Increase of surface CD11a level in response to BCR crosslinking in the presence of BAFF.
(D) MZ B cell differentiation scheme. Low level of self-antigen exposure increases BCR signal strength from constitutive low to intermediate
level, leading to MZ B cell differentiation in the spleen microenvironment.of signal, as determined by the combination of BCR
affinity and form of the ligand. Stimulation with anti-
IgM, which binds to IgC with high affinity, did not re-
veal significant differences between immature and
mature B cells in their calcium responses, with a dose-
dependent decline similar to antigenic stimulation of
immature B cells expressing a high-affinity BCR (Cyster
et al., 1996). In contrast, exposing the IgM BCR oligo-
mer (Reth et al., 2000) to repetitive low-affinity antigen
stimulation may be important in generating a sustained
calcium signal, as postulated for coreceptor-dependent
T cell-positive selection (Werlen et al., 2003). The ATA
BCR used here is unmutated from the germline and rec-














tGui et al., 1999). Since the mouse Thy-1 peptide con-
ains three glycosylation sites (Carlsson and Stigbrand,
984), it is likely that the Thy-16C10 epitope may be re-
etitively arrayed per molecule, suited for inducing a
ustained signaling, similar to other T cell-independent
ntigens. The ATA BCR was originally isolated from the
D5+ B-1 subset, a population of unconventional B
ells that is enriched for BCRs that transduce a rela-
ively high strength of signal (Casola et al., 2004) in
ost immature B cells that precludes further conven-
ional B cell development (Hayakawa et al., 2003), but
hat still allows B-1 cell development (Hayakawa et al.,
999). The use of this BCR, in concert with reducing
he level of self-antigen, appears to be particularly in-
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ventional B cell development, based on a signal strength
hierarchy.
In comparison to the monoclonal BCR mice, imma-
ture B cells in normal mice generate a diverse repertoire
of B cell specificities. In these normal immature B cells,
BCR signal strength is likely to be determined by com-
binations of several components, including BCR affin-
ity, BCR quantity, antigen amount, and antigen forms.
Thus, we expect B cell subset or fate decision in the
wild-type animal to be more complex than in the mo-
noclonal BCR mice studied here. An increase of surface
BCR quantity by transgenic Ig heavy chain expression
is often associated with increased MZ B cell frequency
(Heltemes and Manser, 2002; Martin and Kearney, 2002)
as one parameter of BCR strength. Some generation of
MZ B cells in our transgenic mice in the absence of
Thy-1 may be explained on this basis. However, MZ B
cells in unimmunized or germ-free animals exhibit more
biased BCR usage than FO B cells (Dammers et al.,
1999; Martin and Kearney, 2002; Dammers and Kroese,
2005), suggesting an important role of (self-) antigen-
mediated selection for the MZ B cell subset. Taking all
of these observations into consideration, positive se-
lection by BCRs that have low affinity for certain self-
or commensal antigens appears to be a major contrib-
utor to MZ B cell development in normal animals,
increasing BCR signal strength relative to BCR alone
and leading to differentiation conditions that permit ef-
fective Notch 2 signaling.
BCR signaling strength can also be modulated by ge-
netic alterations of molecules involved in BCR signaling
pathway(s), changing B cell fate. A requirement for the
highest BCR signaling strength in CD5+ B-1 cell devel-
opment is supported by numerous studies using BCR
signaling-deficient/modified mice, indicating that this B
cell subset is most sensitive to changes in BCR signal-
ing (Hayakawa and Hardy, 2000; Cariappa and Pillai,
2002; Casola et al., 2004). In contrast to the B-1 subset,
whose development does not depend on BAFF and
Notch non-BCR signals (Mackay and Browning, 2002;
Tanigaki et al., 2002), FO and MZ B cells are dependent
on such non-BCR signal(s) and it is not as straightfor-
ward to determine their requirement for relative BCR
signal strength from BCR signaling-deficient/modified
mouse models. The loss/mutation of Btk or PLCγ2, me-
diators of signals from the BCR, have previously been
shown to block complete FO B cell maturation (Raw-
lings et al., 1993; Thomas et al., 1993; Wang et al.,
2000), while sparing MZ B cell development. Enhanced
BCR signaling, such as by CD22 or Aiolos deficiency,
reduces MZ B cell frequency, whereas FO B cells re-
main normal or are even elevated, and addition of Btk
deficiency to the Aiolos null background restores MZ
generation (Cariappa et al., 2001; Samardzic et al.,
2002). It is reasonable to interpret these data as indicat-
ing that only very weak BCR signaling allows MZ B cell
entry, whereas FO B cell development proceeds with
stronger signaling (Pillai et al., 2005). On the other hand,
an alternative hypothesis may account for these re-
sults: that a range of BCR signal strength, with lower
and upper bounds, facilitates entry into the MZ B cell
pool, and then increased signaling would render poten-
tial MZ precursors subject to deletion, whereas elimina-tion of Btk on this background could lower signaling
back into an “acceptable” range for MZ B cell selec-
tion. In this view, FO B cells that do not experience
significant BCR crosslinking are benefited from loss of
Aiolos, so more enter the long-lived pool, but handi-
capped by the loss of Btk. Another mutant where en-
hanced BCR signaling is anticipated, CD72 knockout
mice, have reduced FO B cells (Pan et al., 1999), which
might be interpreted as an enhancement of BCR signal-
ing, beyond even the level allowed for FO B cell devel-
opment.
Furthermore, it is unclear whether FO B cell defi-
ciency caused by lack of Btk or PLCγ2 signaling arises
at the point of B cell subset fate decision or at a later
maintenance phase. Since Btk and PLCγ2 are also in-
volved in non-BCR-mediated signaling pathways, such
as for IL-5 and BAFF signaling, respectively (Moon et
al., 2001; Hikida et al., 2003), it is possible that naive
FO B cells may rely more on non-BCR signaling in com-
bination with constitutive tonic BCR signal for their
maintenance, compared with MZ B cells already dif-
ferentiated. In this regard, B-1 cells greatly reduced in
such BCR signal-deficient animals due to absolute reli-
ance by B-1 cells on BCR signal, may also be affecting
on FO B cell generation (Wen et al., 2005), an interest-
ing issue to consider in future investigation.
Although negative selection was predominant over
B-1 cell-positive selection under exposure of normal
Thy-1 self-antigen amount, minor B-1 cells were gener-
ated in our ATA BCR mice and contributed to high se-
rum autoantibody production. We show here that MZ B
cells also contribute to serum antibody levels, though
to a lesser extent than B-1, and FO B cells showed the
lowest titer. In comparison, as expected, there seems
to be an upper threshold for positive impact by self-
antigen. A reduction of serum ATA was observed in
mice overexpressing the Thy-1 transgene and generat-
ing a serum level 10-fold higher than wild-type, sug-
gesting induction of B-1 cell tolerance (data not
shown). These data suggest that the BCR crosslinking
signal within appropriate range is a critical factor in nat-
ural autoantibody secretion, rather than mitogen- or
TLR (toll-like receptor)-mediated signaling alone, in un-
immunized healthy animals. Interestingly, under condi-
tions of low Thy-1 antigen exposure (such as in mice of
RagKO or lck-Thy-1 10 background) expanding MZ B
cells in spleen, ATA B cells in the peritoneal cavity ex-
hibited a phenotype reminiscent of CD5– “B1b” cells, a
B cell subset reported to provide protection from path-
ogens (Alugupalli et al., 2004), suggesting that this B
cell subset could also be a product of positive selec-
tion, which may be contributing to serum autoantibody
in addition to MZ B cells.
Our study highlights the important role of the amount
of self-antigen in B cell development, impacting both
positively and negatively. Newly formed B cells exit
from bone marrow, circulate, and enter peripheral sites
for their maturation. Since B cells directly bind native
(nonprocessed) antigens, developing B cells in the
bloodstream will be constantly exposed to self-anti-
gens where the fate of B cells is delicately regulated.
Though the natural autoreactive B cell repertoire is well
controlled, a change in the amount of self-antigen, such
as by aging, could enhance autoreactive B cell genera-
Immunity
306tion that normally is silenced or ignored, shifting the




ATA IgκTg mouse line 3369, Thy-1KO (“ThyKO”), and 3369Thy-
1KO (“3369ThyKO”), all on a C.B17 background, were described
previously (Hayakawa et al., 2003). Rag-1KO (“RagKO”) and JH KO
mice were backcrossed to BALB/c and C.B17 mice, respectively,
for more than six generations. Studies were performed according
to institutional guidelines for animal use and care (IACUC).
Generation of lck-Thy-1 Transgenic Mice
A mouse Thy-1.1 cDNA was inserted into the lck-hGH vector (Chaf-
fin et al., 1990) for generation of transgenic mice (see Supplemental
Experimental Procedures). Selected candidate Thy-1.1 transgenic
lines were crossed with ThyKO.C57BL/6 mice to obtain an endoge-
nous Thy1.2 KO background. The nonallelic ATA epitope Thy-16C10
expression was restricted to the T-lineage, predominantly by thy-
mocytes, as determined by flow cytometry analysis and tissue ab-
sorption (see Figure S2).
Flow Cytometry Analysis and Monoclonal Antibody Reagents
Multicolor flow cytometry analysis and sorting was carried out
using a FACS-VantageSE with DiVa (BD Biosciences, San Jose,
CA), equipped for three laser excitation; data were analyzed by
FlowJo software (Tree Star, Ashland, OR). Monoclonal antibody
reagents used in this study are listed in the Supplemental Experi-
mental Procedures.
Tissue Section Immunofluorescence Analysis
Frozen spleen section staining and imaging were done as de-
scribed previously (Wen et al., 2005).
BCR Calcium Signaling Response
Spleen cells were surface stained with antibodies to B220 and AA4
to allow distinguishing immature (AA4+) versus mature (AA4–) B220+
B cells, then loaded with Indo-1 in buffer containing Pluronic
F-127. Calcium signaling was analyzed by flow cytometry (405/485
nm ratio) using FlowJo software (Hayakawa et al., 2003).
Thy-1 Antigen Stimulation In Vitro
Soluble Thy-1-containing plasma membrane was prepared from
CD5 KO.C.B17 (Thy-1.2+) mouse thymocytes as previously de-
scribed (Hayakawa et al., 2003). The amount of Thy-1 protein in the
membrane preparation was determined to be 1% of total (Thy-1M),
by densitometry comparison of silver-stained SDS-PAGE gels, in-
cluding a Thy-1KO mouse thymocyte plasma membrane control,
and with an affinity purified Thy-1 protein standard (Gui et al.,
1999). Thy-1M stimulation for 2 day culture was carried out in a
U-bottom 96-well plate using 8 × 104 purified B cells/well in 150 l
culture medium. Cells were pooled from duplicate cultures,
washed, and stained for flow cytometry analysis to determine via-
bility (propidium iodide staining), surface phenotype, cell size, and
recovered total cell numbers.
Serum ATA and Thy-1 Measurements by ELISA Assay
Serum ATA was measured by ELISA assay using 19A4 anti-ATA idi-
otype antibody as a plate coat and anti-mouse IgM coupled with
alkaline phosphatase as detector (Hayakawa et al., 2003). Serum
Thy-1 was measured using anti-pan Thy-1 (G7) as plate coat and
biotin anti-Thy-1.2 (30H12) or biotin anti-Thy-1.1 (HIS51, for lck-
Thy-1 transgenic mouse sera), amplified with HRP-avidin in combi-
nation with TMB (tetramethyl benzidine; BioFX, MD) as detector.
Thy-1M from CD5KO. C.B17 or AKR mice were used as Thy-1.2 or
Thy-1.1 binding standards, respectively.
Notch 2 IC Retroviral Transduction and Culture
A cDNA clone of the mouse Notch 2 intracellular domain (N2IC)
was prepared by PCR amplification and inserted into pCR2.1-
































































clone was digested and ligated into the pMIG vector (MSCV-IRES-
FP) (See Supplemental Experimental Procedures). N2IC-pMIG
lasmid DNA was introduced into the Phoenix virus packaging cell
ine by the standard calcium-phosphate coprecipitation method.
igh-titer virus supernatant was added to IL-7 preexpanded (5
ays) bone marrow cells from 3369 ThyKO mice (>95% surface
gM+ AA4hi+ immature B cells) for spin transfection, then incubated
t 37°C for an additional 3 hr. One day after transfection (5%–10%
2IC-GFP+, 60%–70% vector-GFP+), IL-7 was withdrawn, cells
ere divided, and the culture continued at 2.5 × 106 cells/ml in 24-
ell plate for 5–7 days in fresh medium without or with supple-
ents: Thy-1M 1 ng/ml, BAFF (Apotech, San Diego, CA) 0.1 g/ml,
lone or in combination.
one Marrow Stem Cell Transfer
ematopoietic stem cells (HSC) were enriched from 1-month-old
one marrow of 3369ThyKO mice as c-Kithi+ IL-7R– AA4+ Lineage–
ells by cell sorting. 3–4 × 104 HSC/mouse were injected intrave-
ously into lightly irradiated (300R) RagKO recipients; mice were
nalyzed 1–6 months after transfer.
upplemental Data
upplemental Data include four figures and Supplemental Experi-
ental Procedures and can be found with this article online at
ttp://www.immunity.com/cgi/content/full/23/3/297/DC1/.
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